CDC Finally Releases Signal Detection Analysis of VAERS Data for mRNA "Vaccines"

The New Year has brought some not-so-great results for the manufacturers of the mRNA shots.

Since these products were rolled out, the number of adverse events noted in the CDC vaccine Adverse Event reporting System (VAERS) has skyrocketed. Now, anyone can report to VAERS (although there are criminal penalties for filing a false report) and post-marketing systems such as VAERS are generally thought to capture between one and ten percent of all adverse events. (Some estimates are even lower, but nobody really knows.) For these reasons, VAERS reports are not considered proof of causality. Nevertheless there are recognized ways of extracting a signal from the raw data. One such method is called Proportional Report Ratio analysis.

Now I’m going to get all mathematical on you for just a minute, but bear with me, okay? Proportional Report Ratio analysis is a method in which the number of adverse events of a specific type (e.g., myocarditis) attributed to a drug is divided by the total number of adverse events associated with that drug. This ratio is then compared to that of the comparator drugs (in the case of the covid vax, the comparators would be all non-covid vaccines). If the Proportional Rate Ratio (PRR) of the drug of interest is twice that of the comparator, this is considered a signal meriting further investigation.

The CDC promised to carry out PRR analysis weekly, in their standard Operating Procedures published on 29 January 2021, and reaffirmed this promise in their Revised Standard Operating Procedures released 2 February 2022. The Standard Operating Procedures also stipulated that the FDA was to carry out their own analysis biweekly, by means of another method called Empirical Bayesian Data Mining.

Now, after months and months of dissembling, the CDC has finally have released their results, and the Epoch Times has kindly provided links to the data tables. The results are eye-opening, to say the least.

The analysis covered adverse events reported from 14 December 2020 through 29 July 2022. Remember the PRR for a given event has to be at least 2:1 to be considered a “signal.” There were over seven hundred such signals. Here is just a partial list:

• Pulmonary: Lung opacity, increased respiratory rate, pulmonary pain, acute respiratory failure, decreased oxygen saturation, atypical pneumonia

• Neurological: Ischaemic stroke, cerebellar stroke, anosmia, ageusia, Bell’s palsy, electric shock sensation

• Cardiovascular: myocarditis, pericarditis, thrombectomy, increased blood pressure, pulmonary thrombosis, left ventricular failure, acute cardiac failure, stent placement, acute left ventricular failure, intracardiac thrombus, right ventricular dilation, portal vein thrombosis, implantable cardiac monitor insertion, myocardial strain, mesenteric vein thrombosis, jugular vein thrombosis, thromboembolectomy, coronary angioplasty, vascular dementia, embolic stroke, hypertensive emergency, coronary artery thrombosis, pulmonary infarction, increased troponin level, acute myocardial infarction, coronary artery stent insertion, deep vein thrombosis, coronary artery occlusion, cardiorespiratory arrest

• Hepatic: Liver injury, elevated liver enzymes, liver disorder, hepatic mass, hepatic cirrhosis

• Renal: End-stage renal disease, chronic kidney disease, acute kidney injury

Had enough? We’re just getting started. As soon as these shots were rolled out, women were complaining of a variety of effects on their reproductive systems. The CDC analysis linked the mRNA shots to heavy menstrual bleeding, intermenstrual bleeding, polymenorrhea, post-menopausal hemorrhage, abnormal uterine bleeding, oligomenorrhea, menstrual disorder, irregular menstruation, premenstrual pain, premenstrual syndrome, ovulation disorder, hypomenorrhea, and amenorrhea.

As they used to say on the late-night infomercials – “But wait – there’s more!”

The CDC analysis also found signals for colon cancer, metastatic breast cancer, thyroid cancer, lung adenocarcinoma, pancreatic carcinoma, metastases to the lymph nodes, metastases to the central nervous system, metastases to the liver, and metastases to the bone.

Miscellaneous effects included decreased body height, superinfection, critical illness, amyloidosis, hospitalization, perforated appendicitis, and multiple organ dysfunction syndrome. Not to mention death.

But bigger than the signal for any of these was that for “serious vaccine breakthrough infection,” for which the PRR was a whopping 315 times that of comparator products. So much for the vaunted “effectiveness” of these products.

We still haven’t seen the results of the FDA’s promised analysis (if they’ve ever even done it), but in an accompanying letter, the CDC told the Times that the center’s results “generally corroborated the findings from Empirical Bayesian Data Mining, revealing no additional unexpected safety signals.” That is not terribly reassuring.